SCHEMBL4053620

SCHEMBL4053620

Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)NCCSc4ccccn4)cc3)cc2n(C)c1=O

nearest known ligand 0.77

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 16/20 0.77
ADORA3 P0DMS8 10/20 0.77
ADORA1 P30542 10/20 0.77
KMT2A Q03164 2/20 0.53
MAPT P10636 1/20 0.53
ALDH1A1 P00352 2/20 0.52
MEN1 O00255 1/20 0.52
PKM P14618 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
ADORA2A P29274 4/20 0.50
USP2 O75604 1/20 0.50
TSHR P16473 1/20 0.50
HTT P42858 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4053174 0.90 ADORA2B (0.72) ADORA2BADORA3ADORA1PKMADORA2A
SCHEMBL4056690 0.87 ADORA2B (1.00) ADORA2BADORA3ADORA1ADORA2A
SCHEMBL4053822 0.83 ADORA2B (1.00) ADORA2BADORA3ADORA1ADORA2A
SCHEMBL4063088 0.83 ADORA2B (0.83) ADORA2BADORA3ADORA1PKMADORA2A
SCHEMBL4053837 0.80 ADORA2B (0.73) ADORA2BADORA3ADORA1KMT2AALDH1A1
SCHEMBL4058221 0.80 ADORA2B (1.00) ADORA2BADORA3ADORA1ADORA2A
SCHEMBL4051486 0.79 ADORA2B (0.71) ADORA2BADORA3ADORA1ALDH1A1ADORA2A
SCHEMBL4050202 0.79 ADORA2B (0.87) ADORA2BADORA3ADORA1ADORA2A
SCHEMBL4063349 0.79 ADORA2B (0.68) ADORA2BADORA3ADORA1ALDH1A1ADORA2A
SCHEMBL4050752 0.78 ADORA2B (0.88) ADORA2BADORA3ADORA1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504398-B2 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation LABORATORIOS ALMIRALL S.A. (ES) 2009-03-17 US disclosed
EP-1492793-B1 NEW-4-(PYRROLOPYRIMIDIN-6-YL)BENZENESULPHONAMIDE DERIVATIVES ALMIRALL LAB (ES) 2008-01-16 EP disclosed